Marginal zone lymphoma treatment evolves with promising CAR T-cell therapies, addressing unmet needs in aggressive cases and improving patient outcomes.
Maria L. Palomba, MD
Advertisement
Articles by Maria L. Palomba, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
The Targeted Pulse: Clinical Advancements and FDA News
2
Beyond Chemotherapy: Evaluating the Efficacy of Ribociclib, Letrozole in LGSOC
3
The Strategic Shift in SCLC Management: Bone Marrow Preservation
4
Relacorilant Demonstrates Significant OS in Platinum-Resistant Ovarian Cancer
5